Determination of bovine serum albumin conjugated drugs by immobilization as microarrays and oblique-incidence reflectivity difference microscopy

Yung Shin Sun, Kit Lam, X. D. Zhu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Human serum is a mixture of various proteins which may interact with drugs. Therefore, it is of interest to investigate the binding kinetics of pharmaceuticals with their corresponding antibodies in serum. In this article, microarrays and a label-free biosensor were used to study these interactions. Microarrays provide a high-throughput platform for characterizing biomolecular interactions, and the label-free oblique-incidence reflectivity difference biosensor avoids the drawbacks of fluorescence-based methods. The experimental results show that the binding affinities between most of the drugs and their antibodies were reduced in human serum because the bulky proteins block the access to or reduce the stability of the reaction complexes. Therefore, one should be mindful when in vitro or in vivo testing the efficiency of potential drugs and their antibodies.

Original languageEnglish (US)
Pages (from-to)475-485
Number of pages11
JournalInstrumentation Science and Technology
Volume42
Issue number4
DOIs
StatePublished - Jul 4 2014

Fingerprint

Microarrays
Bovine Serum Albumin
antibodies
immobilization
albumins
Antibodies
serums
reflectivity
microscopy
serum
Microscopic examination
drugs
drug
incidence
antibody
reflectance
bioinstrumentation
Biosensors
Labels
Pharmaceutical Preparations

Keywords

  • drug-antibody binding affinity
  • label-free
  • microarray
  • oblique-incidence reflectivity difference (OI-RD)

ASJC Scopus subject areas

  • Instrumentation
  • Chemical Engineering(all)
  • Environmental Science(all)

Cite this

@article{ea71f32fbf5a4250a89b880c46ce0dab,
title = "Determination of bovine serum albumin conjugated drugs by immobilization as microarrays and oblique-incidence reflectivity difference microscopy",
abstract = "Human serum is a mixture of various proteins which may interact with drugs. Therefore, it is of interest to investigate the binding kinetics of pharmaceuticals with their corresponding antibodies in serum. In this article, microarrays and a label-free biosensor were used to study these interactions. Microarrays provide a high-throughput platform for characterizing biomolecular interactions, and the label-free oblique-incidence reflectivity difference biosensor avoids the drawbacks of fluorescence-based methods. The experimental results show that the binding affinities between most of the drugs and their antibodies were reduced in human serum because the bulky proteins block the access to or reduce the stability of the reaction complexes. Therefore, one should be mindful when in vitro or in vivo testing the efficiency of potential drugs and their antibodies.",
keywords = "drug-antibody binding affinity, label-free, microarray, oblique-incidence reflectivity difference (OI-RD)",
author = "Sun, {Yung Shin} and Kit Lam and Zhu, {X. D.}",
year = "2014",
month = "7",
day = "4",
doi = "10.1080/10739149.2014.880149",
language = "English (US)",
volume = "42",
pages = "475--485",
journal = "Instrumentation Science and Technology",
issn = "1073-9149",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Determination of bovine serum albumin conjugated drugs by immobilization as microarrays and oblique-incidence reflectivity difference microscopy

AU - Sun, Yung Shin

AU - Lam, Kit

AU - Zhu, X. D.

PY - 2014/7/4

Y1 - 2014/7/4

N2 - Human serum is a mixture of various proteins which may interact with drugs. Therefore, it is of interest to investigate the binding kinetics of pharmaceuticals with their corresponding antibodies in serum. In this article, microarrays and a label-free biosensor were used to study these interactions. Microarrays provide a high-throughput platform for characterizing biomolecular interactions, and the label-free oblique-incidence reflectivity difference biosensor avoids the drawbacks of fluorescence-based methods. The experimental results show that the binding affinities between most of the drugs and their antibodies were reduced in human serum because the bulky proteins block the access to or reduce the stability of the reaction complexes. Therefore, one should be mindful when in vitro or in vivo testing the efficiency of potential drugs and their antibodies.

AB - Human serum is a mixture of various proteins which may interact with drugs. Therefore, it is of interest to investigate the binding kinetics of pharmaceuticals with their corresponding antibodies in serum. In this article, microarrays and a label-free biosensor were used to study these interactions. Microarrays provide a high-throughput platform for characterizing biomolecular interactions, and the label-free oblique-incidence reflectivity difference biosensor avoids the drawbacks of fluorescence-based methods. The experimental results show that the binding affinities between most of the drugs and their antibodies were reduced in human serum because the bulky proteins block the access to or reduce the stability of the reaction complexes. Therefore, one should be mindful when in vitro or in vivo testing the efficiency of potential drugs and their antibodies.

KW - drug-antibody binding affinity

KW - label-free

KW - microarray

KW - oblique-incidence reflectivity difference (OI-RD)

UR - http://www.scopus.com/inward/record.url?scp=84900388871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900388871&partnerID=8YFLogxK

U2 - 10.1080/10739149.2014.880149

DO - 10.1080/10739149.2014.880149

M3 - Article

AN - SCOPUS:84900388871

VL - 42

SP - 475

EP - 485

JO - Instrumentation Science and Technology

JF - Instrumentation Science and Technology

SN - 1073-9149

IS - 4

ER -